Fig. 6
From: A subset of diffuse-type gastric cancer is susceptible to mTOR inhibitors and checkpoint inhibitors
A hypothesis on the relationship between diffuse-type GCs in clusters I and II, and intestinal-type GCs in TCGA cohort. a Distribution of CIN, MSI, EBV, and GS subtypes in diffuse-type GCs in clusters I and II, and intestinal-type GCs in TCGA cohort. *** P < 0.001 (Chi-square test between two populations). b Distribution of GC cells with various mutation numbers in diffuse-type GCs in clusters I and II, and intestinal-type GCs in TCGA cohort. *** P < 0.001 (Chi-square test between two populations). c A hypothesis on the development of diffuse-type GCs in clusters I and II, and intestinal-type GCs from normal gastric epithelial cells